<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dinarello A</submitter><funding>NIAID NIH HHS</funding><funding>NIH</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>e2306476120</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10636342</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120(45)</volume><pubmed_abstract>The IL-1 Family member IL-38 has been characterized primarily as an antiinflammatory cytokine in human and mouse models of systemic diseases. Here, we examined the role of IL-38 in the murine small intestine (SI). Immunostaining of SI revealed that IL-38 expression partially confines to intestinal stem cells. Cultures of intestinal organoids reveal IL-38 functions as a growth factor by increasing organoid size via inducing WNT3a. In contrast, organoids from IL-38-deficient mice develop more slowly. This reduction in size is likely due to the downregulation of intestinal stemness markers (i.e., &lt;i>Fzd5&lt;/i>, &lt;i>Ephb2&lt;/i>, and &lt;i>Olfm4&lt;/i>) expression compared with wild-type organoids. The IL-38 binding to IL-1R6 and IL-1R9 is still a matter of debate. Therefore, to analyze the molecular mech</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>IL-38 regulates intestinal stem cell homeostasis by inducing WNT signaling and beneficial IL-1β secretion.</pubmed_title><pmcid>PMC10636342</pmcid><funding_grant_id>R01 GM139892</funding_grant_id><funding_grant_id>R03 AI151651</funding_grant_id><funding_grant_id>AI 15614</funding_grant_id><funding_grant_id>R01 AI015614</funding_grant_id><funding_grant_id>R56 AI015614</funding_grant_id><funding_grant_id>R03 AI156560</funding_grant_id><pubmed_authors>Amo-Aparicio J</pubmed_authors><pubmed_authors>Tesoriere A</pubmed_authors><pubmed_authors>de Graaf DM</pubmed_authors><pubmed_authors>Marchetti C</pubmed_authors><pubmed_authors>Ghirardo R</pubmed_authors><pubmed_authors>Redzic JS</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Azam T</pubmed_authors><pubmed_authors>Atif SM</pubmed_authors><pubmed_authors>Dinarello A</pubmed_authors><pubmed_authors>May M</pubmed_authors><pubmed_authors>Webber WS</pubmed_authors><pubmed_authors>Eisenmesser EZ</pubmed_authors><pubmed_authors>Gaballa JM</pubmed_authors><pubmed_authors>Dinarello CA</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-38 regulates intestinal stem cell homeostasis by inducing WNT signaling and beneficial IL-1β secretion.</name><description>The IL-1 Family member IL-38 has been characterized primarily as an antiinflammatory cytokine in human and mouse models of systemic diseases. Here, we examined the role of IL-38 in the murine small intestine (SI). Immunostaining of SI revealed that IL-38 expression partially confines to intestinal stem cells. Cultures of intestinal organoids reveal IL-38 functions as a growth factor by increasing organoid size via inducing WNT3a. In contrast, organoids from IL-38-deficient mice develop more slowly. This reduction in size is likely due to the downregulation of intestinal stemness markers (i.e., &lt;i>Fzd5&lt;/i>, &lt;i>Ephb2&lt;/i>, and &lt;i>Olfm4&lt;/i>) expression compared with wild-type organoids. The IL-38 binding to IL-1R6 and IL-1R9 is still a matter of debate. Therefore, to analyze the molecular mech</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-06-01T10:51:05.136Z</modification><creation>2026-04-08T11:32:18.377Z</creation></dates><accession>S-EPMC10636342</accession><cross_references><pubmed>37906644</pubmed><doi>10.1073/pnas.2306476120</doi></cross_references></HashMap>